The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship
Marin Kollef(Washington University in St. Louis), Richard G. Wunderink(Northwestern University), Matteo Bassetti(Ospedale Policlinico San Martino), Charles‐Édouard Luyt(Inserm), Tobias Welte(Medizinische Hochschule Hannover), Jeffrey Lipman(Queensland Health), Jason P. Burnham(Washington University in St. Louis), George Dimοpoulos(National and Kapodistrian University of Athens), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Bruno François(Inserm), Maarten J. Postma(University Medical Center Groningen), David P. Nicolau(Hartford Hospital), José Garnacho‐Montero(Hospital Universitario Virgen Macarena)
Cited by 150
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k